ENDURANT CAPITAL MANAGEMENT LP Axsome Therapeutics, Inc. Transaction History

ENDURANT CAPITAL MANAGEMENT LP portfolio value:

$0
portfolio value

ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:

+16.50%
quarter

Axsome Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -15.24K shares -584K $44.62 0
Q2 2022 share Decrease -84.80% -85.05K shares -3.56M $38.3 15.24K
Q1 2022 share Increase +80.30% 44.67K shares 2.04M $41.39 100.29K
Q4 2021 share Increase +6.88% 3.58K shares 386K $38.02 55.62K
Q3 2021 share Increase 0.00% 52.04K shares 1.71M $32.96 52.04K
Q2 2020 share Decrease -100.00% -12.36K shares -728K $82.28 0
Q1 2020 share Increase +10.90% 1.21K shares -425K $58.83 12.36K
Q4 2019 share Increase 0.00% 11.15K shares 1.15M $103.36 11.15K
Q2 2019 share Decrease -100.00% -52.26K shares -744K $25.75 0
Q1 2019 share Decrease -75.01% -156.92K shares 154K $14.23 52.26K
Q4 2018 share Increase +119.78% 114.01K shares 262K $2.82 209.19K
Q3 2018 share Increase 0.00% 95.18K shares 328K $3.45 95.18K